Accure Acne's New FDA Clearance for Laser Treatment
The Accure Laser System has made significant strides in treating mild to severe inflammatory acne vulgaris, now officially recognized for long-term usage. This groundbreaking achievement by Accure Acne, Inc.™ showcases its dedication to developing innovative acne treatments that enhance patient outcomes.
CEO's Vision and Commitment
Christopher Carlton, Co-Founder and CEO of Accure Acne, expressed pride in this advancement, stating, "This achievement cannot be overstated." He emphasized that after years of rigorous research and clinical trials, the Accure Laser offers a sustainable, drug-free alternative for patients.
Innovative Technology Behind the Treatment
The Accure Laser utilizes a unique 1726 nm wavelength. This innovative approach allows precise control of the treatment depth, ensuring maximum effectiveness on the sebaceous glands responsible for acne. A series of clinical trials conducted in various regions confirmed an impressive 70% reduction in inflammatory lesions six months after treatment.
Satisfaction Across Global Markets
Since its limited commercial release, the Accure Laser has garnered positive responses, with providers and patients reporting satisfaction ratings exceeding 4.4 out of 5. The expansion of the Accure Laser System’s availability includes regions such as Europe and Asia Pacific, where individuals across different skin types and acne severities can achieve safe and effective results.
Collaboration and Future Directions
Emil Tanghetti, MD, a significant figure in the development of the Accure system, acknowledged the collaborative effort between Accure, Quanta System, and various clinical experts. He noted how employing temperature during treatment sets the Accure Laser apart from traditional methods.
Potential for Other Skin Conditions
The unique platform of the Accure Laser hints at possibilities for treating numerous other skin conditions, demonstrating its flexibility and adaptability in dermatological treatments.
About Accure Acne, Inc.
Accure Acne is committed to addressing the harsh realities of acne, which can deeply affect a patient's social, psychological, and economic wellbeing. As the first to achieve both CE Mark certification and FDA clearance for its 1726 nm-based platform, Accure is rapidly gaining traction in various global markets.
Contact Information
For more details about Accure and its innovative treatments, potential partners and interested parties are encouraged to reach out. Contact: Vlad Paul-Blanc, (720) 615-3573.
Frequently Asked Questions
What is the Accure Laser System?
The Accure Laser System is a state-of-the-art device designed for the long-term treatment of acne, using a specific wavelength to target sebaceous glands effectively.
How effective is the Accure Laser System?
Clinical trials have shown an average reduction of 70% in inflammatory lesions six months post-treatment, highlighting its efficacy across various skin types.
Where is the Accure Laser System available?
The Accure Laser System is available in numerous regions, including Europe and Asia, with plans for further expansion to reach more patients globally.
What does FDA clearance mean for the Accure Laser System?
FDA clearance means that the Accure Laser System has met specific safety and efficacy standards, allowing it to be used legally for acne treatment in the United States.
Can the Accure Laser treat other skin conditions?
Research indicates the potential for the Accure Laser to be adapted for various dermatological treatments beyond acne, making it a versatile tool for clinicians.
